Role of microglia in CNS autoimmunity

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Goldmann, Tobias ^a   Prinz, Marco ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD40 LIGAND; CYCLOOXYGENASE 2; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 5; MYELIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEOLIPID PROTEIN; RANTES; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; CYTOKINE; SUPPRESSOR OF CYTOKINE SIGNALING;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATION; HEMATOPOIESIS; HUMAN; INFLAMMATION; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; PARALYSIS; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; TISSUE INJURY; TISSUE REPAIR; WEIGHT REDUCTION; WHITE MATTER; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; NERVE CELL; PATHOLOGY; SIGNAL TRANSDUCTION; TH1 TH2 BALANCE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; MICROGLIA; MULTIPLE SCLEROSIS; MYELOID CELLS; NEURONS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TH1-TH2 BALANCE;

EID: 84880139919     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/208093     Document Type: Review

References (94)

1. Hewagama A., Richardson B., The genetics and epigenetics of autoimmune diseases. Journal of Autoimmunity 2009 33 1 3 11 2-s2.0-67349236051 10.1016/j.jaut.2009.03.007
2. Lassmann H., van Horssen J., Mahad D., Progressive multiple sclerosis: pathology and pathogenesis. Nature Reviews Neurology 2012 8 11 647 656 10.1038/nrneurol.2012.168
3. Luessi F., Siffrin V., Zipp F., Neurodegeneration in multiple sclerosis: novel treatment strategies. Expert Reviews 2012 12 9 1061 1077
4. Brendecke S. M., Prinz M., How type I interferons shape myeloid cell function in CNS autoimmunity. Journal of Leukocyte Biology 2012 92 3 479 488 10.1189/jlb.0112043
5. Axtell R. C., Raman C., Janus-like effects of type I interferon in autoimmune diseases. Immunological Reviews 248 23 35
6. Ransohoff R. M., Animal models of multiple sclerosis: the good, the bad and the bottom line. Nature Neuroscience 2012 15 8 1074 1077 10.1038/nn.3168
7. Gao Z., Tsirka S. E., Animal models of MS reveal multiple roles of microglia in disease pathogenesis. Neurology Research International 2011 2011 1 9 383087 10.1155/2011/383087
8. Kuerten S., Angelov D. N., Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice-a step towards understanding the complexity of multiple sclerosis. Annals of Anatomy 2008 190 1 1 15 2-s2.0-38649124013 10.1016/j.aanat.2007.11.001
9. Dann A., Poeck H., Croxford A. L., Gaupp S., Kierdorf K., Knust M., Pfeifer D., Maihoefer C., Endres S., Kalinke U., Meuth S. G., Wiendl H., Knobeloch K.-P., Akira S., Waisman A., Hartmann G., Prinz M., Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS. Nature Neuroscience 2012 15 1 98 106 2-s2.0-84655170111 10.1038/nn.2964
10. Prinz M., Schmidt H., Mildner A., Knobeloch K.-P., Hanisch U.-K., Raasch J., Merkler D., Detje C., Gutcher I., Mages J., Lang R., Martin R., Gold R., Becher B., Brück W., Kalinke U., Distinct and nonredundant in vivo functions of IFNAR on myeloid cells Limit autoimmunity in the central nervous system. Immunity 2008 28 5 675 686 2-s2.0-43049177588 10.1016/j.immuni.2008.03. 011
11. Prinz M., Kalinke U., New lessons about old molecules: how type I interferons shape Th1/Th17-mediated autoimmunity in the CNS. Trends in Molecular Medicine 2010 16 8 379 386 2-s2.0-77955423259 10.1016/j.molmed.2010.06.001
12. Teige I., Liu Y., Issazadeh-Navikas S., IFN- β inhibits T cell activation capacity of central nervous system APCs. The Journal of Immunology 2006 177 6 3542 3553 2-s2.0-33748479268 (Pubitemid 44359885)
13. Guo B., Chang E. Y., Cheng G., The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. The Journal of Clinical Investigation 2008 118 5 1680 1690 2-s2.0-43049101640 10.1172/JCI33342 (Pubitemid 351632372)
14. Ransohoff R. M., Perry V. H., Microglial physiology: unique stimuli, specialized responses. Annual Review of Immunology 2009 27 119 145 2-s2.0-67650966680 10.1146/annurev.immunol.021908.132528
15. Saijo K., Glass C. K., Microglial cell origin and phenotypes in health and disease. Nature Reviews Immunology 2011 11 11 775 787 2-s2.0-80355143546 10.1038/nri3086
16. Aguzzi A., Barres B. A., Bennett M. L., Microglia: scapegoat, saboteur, or something else? Science 2013 339 6116 156 161
17. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M. F., Conway S. J., Ng L. G., Stanley E. R., Samokhvalov I. M., Merad M., Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010 330 6005 841 845 2-s2.0-78149360132 10.1126/science.1194637
18. Schulz C., Perdiguero E. G., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., Prinz M., Wu B., Jacobsen S. E. W., Pollard J. W., Frampton J., Liu K. J., Geissmann F., A lineage of myeloid cells independent of myb and hematopoietic stem cells. Science 2012 335 6077 86 90 2-s2.0-84859508307 10.1126/science.1219179
19. Kierdorf K., Erny D., Goldmann T., Sander V., Schulz C., Perdiguero E. G., Wieghofer P., Heinrich A., Riemke P., Hölscher C., Müller D. N., Luckow B., Brocker T., Debowski K., Fritz G., Opdenakker G., Diefenbach A., Biber K., Heikenwalder M., Geissmann F., Rosenbauer F., Prinz M., Microglia emerge from erythromyeloid precursors via Pu. 1- and Irf8-dependent pathways. Nature Neuroscience 2013 16 3 273 280 10.1038/nn.3318
20. Prinz M., Priller J., Sisodia S. S., Ransohoff R. M., Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nature Neuroscience 2011 14 10 1227 1235 2-s2.0-80053233055 10.1038/nn.2923
21. Ajami B., Bennett J. L., Krieger C., Tetzlaff W., Rossi F. M. V., Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nature Neuroscience 2007 10 12 1538 1543 2-s2.0-36448994709 10.1038/nn2014 (Pubitemid 350175883)
22. Ajami B., Bennett J. L., Krieger C., McNagny K. M., Rossi F. M. V., Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nature Neuroscience 2011 14 9 1142 1150 2-s2.0-80052246111 10.1038/nn.2887
23. Mildner A., Schlevogt B., Kierdorf K., Böttcher C., Erny D., Kummer M. P., Quinn M., Brück W., Bechmann I., Heneka M. T., Priller J., Prinz M., Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. The Journal of Neuroscience 2011 31 31 11159 11171 2-s2.0-79961234274 10.1523/JNEUROSCI.6209-10.2011
24. + monocytes only under defined host conditions. Nature Neuroscience 2007 10 12 1544 1553 2-s2.0-36448955070 10.1038/nn2015 (Pubitemid 350175884)
25. Simard A. R., Soulet D., Gowing G., Julien J.-P., Rivest S., Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006 49 4 489 502 2-s2.0-32344440522 10.1016/j.neuron.2006.01.022 (Pubitemid 43221886)
26. Davalos D., Grutzendler J., Yang G., Kim J. V., Zuo Y., Jung S., Littman D. R., Dustin M. L., Gan W.-B., ATP mediates rapid microglial response to local brain injury in vivo. Nature Neuroscience 2005 8 6 752 758 2-s2.0-22244464662 10.1038/nn1472 (Pubitemid 43085841)
27. Nimmerjahn A., Kirchhoff F., Helmchen F., Neuroscience: resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005 308 5726 1314 1318 2-s2.0-19744380563 10.1126/science.1110647 (Pubitemid 40746128)
28. Djukic M., Mildner A., Schmidt H., Czesnik D., Brück W., Priller J., Nau R., Prinz M., Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. Brain 2006 129 9 2394 2403 2-s2.0-33749258893 10.1093/brain/awl206 (Pubitemid 44522124)
29. Ponomarev E. D., Veremeyko T., Barteneva N., Krichevsky A. M., Weiner H. L., MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP- α -PU.1 pathway. Nature Medicine 2011 17 1 64 70 2-s2.0-78651247933 10.1038/nm.2266
30. Mantovani A., Biswas S. K., Galdiero M. R., Sica A., Locati M., Macrophage plasticity and polarization in tissue repair and remodelling. The Journal of Pathology 2013 229 2 176 185 10.1002/path.4133
31. Qin H., Yeh W.-I., De Sarno P., Holdbrooks A. T., Liu Y., Muldowney M. T., Reynolds S. L., Yanagisawa L. L., Fox T. H. III, Park K., Harrington L. E., Raman C., Benveniste E. N., Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation. Proceedings of the National Academy of Sciences of the United States of America 2012 109 13 5004 5009 2-s2.0-84859473951 10.1073/pnas.1117218109
32. Tremblay M. È., The role of microglia at synapses in the healthy CNS: novel insights from recent imaging studies. Neuron Glia Biology 2011 7 1 67 76 10.1017/S1740925X12000038
33. Blank T., Prinz M., Microglia as modulators of cognition and neuropsychiatric disorders. Glia 2013 61 1 62 70 10.1002/glia.22372
34. Fitzner D., Schnaars M., Van Rossum D., Krishnamoorthy G., Dibaj P., Bakhti M., Regen T., Hanisch U.-K., Simons M., Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. Journal of Cell Science 2011 124 3 447 458 2-s2.0-79551542416 10.1242/jcs.074088
35. Benveniste E. N., Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. Journal of Molecular Medicine 1997 75 3 165 173 2-s2.0-0030970058 10.1007/s001090050101 (Pubitemid 27132679)
36. Van Der Valk P., Amor S., Preactive lesions in multiple sclerosis. Current Opinion in Neurology 2009 22 3 207 213 2-s2.0-67049099173 10.1097/WCO.0b013e32832b4c76
37. Singh S., Metz I., Amor S., van der Valk P., Stadelmann C., Brück W., Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons. Acta Neuropathologica 2013 125 4 595 608 10.1007/s00401-013-1082-0
38. Heppner F. L., Greter M., Marino D., Falsig J., Raivich G., Hövelmeyer N., Waisman A., Rülicke T., Prinz M., Priller J., Becher B., Aguzzi A., Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nature Medicine 2005 11 2 146 152 2-s2.0-20044376483 10.1038/nm1177 (Pubitemid 40321349)
39. Popovic N., Schubart A., Goetz B. D., Zhang S.-C., Linington C., Duncan D., Inhibition of autoimmune encephalomyelitis by a tetracycline. Annals of Neurology 2002 51 2 215 223 2-s2.0-0036157268 10.1002/ana.10092 (Pubitemid 34111444)
40. Bhasin M., Wu M., Tsirka S. E., Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis. BMC Immunology 2007 8, article 10 2-s2.0-34547763842 10.1186/1471-2172-8-10 (Pubitemid 47226069)
41. Zipfel P. F., Skerka C., Complement regulators and inhibitory proteins. Nature Reviews Immunology 2009 9 10 729 740 2-s2.0-70349437186 10.1038/nri2620
42. Ramaglia V., Hughes T. R., Donev R. M., Ruseva M. M., Wu X., Huitinga I., Baas F., Neal J. W., Morgan B. P., C3-dependent mechanism of microglial priming relevant to multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 2012 109 3 965 970 2-s2.0-84856390379 10.1073/pnas.1111924109
43. Ponomarev E. D., Maresz K., Tan Y., Dittel B. N., CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. The Journal of Neuroscience 2007 27 40 10714 10721 2-s2.0-35148835215 10.1523/JNEUROSCI.1922- 07.2007 (Pubitemid 47535871)
44. Krausgruber T., Blazek K., Smallie T., Alzabin S., Lockstone H., Sahgal N., Hussell T., Feldmann M., Udalova I. A., IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nature Immunology 2011 12 3 231 238 2-s2.0-79951671510 10.1038/ni.1990
45. Ambros V., The functions of animal microRNAs. Nature 2004 431 7006 350 355 2-s2.0-4644309196 10.1038/nature02871 (Pubitemid 39265675)
46. Yoshimura A., Naka T., Kubo M., SOCS proteins, cytokine signalling and immune regulation. Nature Reviews Immunology 2007 7 6 454 465 2-s2.0-34249660614 10.1038/nri2093 (Pubitemid 46834848)
47. Hanisch U.-K., Microglia as a source and target of cytokines. Glia 2002 40 2 140 155 2-s2.0-0036849018 10.1002/glia.10161 (Pubitemid 35337372)
48. Olson J. K., Miller S. D., Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. The Journal of Immunology 2004 173 6 3916 3924 2-s2.0-4644232615 (Pubitemid 39280755)
49. Schmitz T., Chew L.-J., Cytokines and myelination in the central nervous system. The Scientific World Journal 2008 8 1119 1147 2-s2.0-56749175020 10.1100/tsw.2008.140
50. Merson T. D., Binder M. D., Kilpatrick T. J., Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS. NeuroMolecular Medicine 2010 12 2 99 132 2-s2.0-77956394596 10.1007/s12017-010-8112-z
51. Weber A., Wasiliew P., Kracht M., Interleukin-1 (IL-1) pathway. Science Signaling 2010 3 105 2-s2.0-77952295021 10.1126/scisignal.3105cm1
52. Juedes A. E., Hjelmström P., Bergman C. M., Neild A. L., Ruddle N. H., Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. The Journal of Immunology 2000 164 1 419 426 2-s2.0-0033961796 (Pubitemid 30013017)
53. Kaltschmidt C., Kaltschmidt B., Lannes-Vieira J., Kreutzberg G. W., Wekerle H., Baeuerle P. A., Gehrmann J., Transcription factor NF- B is activated in microglia during experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 1994 55 1 99 106 2-s2.0-0028172144 10.1016/0165-5728(94)90151-1 (Pubitemid 24356811)
54. Waetzig V., Czeloth K., Hidding U., Mielke K., Kanzow M., Brecht S., Goetz M., Lucius R., Herdegen T., Hanisch U.-R., c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia 2005 50 3 235 246 2-s2.0-20044389119 10.1002/glia.20173 (Pubitemid 40769853)
55. Ellrichmann G., Thöne J., Lee D.-H., Rupec R. A., Gold R., Linker R. A., Constitutive activity of NF- B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation. Journal of Neuroinflammation 2012 9, article 15 2-s2.0-84855992548 10.1186/1742-2094-9-15
56. van Loo G., De Lorenzi R., Schmidt H., Huth M., Mildner A., Schmidt-Supprian M., Lassmann H., Prinz M. R., Pasparakis M., Inhibition of transcription factor NF- B in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nature Immunology 2006 7 9 954 961 2-s2.0-33747609345 10.1038/ni1372 (Pubitemid 44263909)
57. Raasch J., Zeller N., Van Loo G., Merkler D., Mildner A., Erny D., Knobeloch K.-P., Bethea J. R., Waisman A., Knust M., Del Turco D., Deller T., Blank T., Priller J., Brück W., Pasparakis M., Prinz M., I B kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF- B in the central nervous system. Brain 2011 134 4 1184 1198 2-s2.0-79953672493 10.1093/brain/awq359
58. Murphy C. A., Langrish C. L., Chen Y., Blumenschein W., McClanahan T., Kastelein R. A., Sedgwick J. D., Cua D. J., Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. The Journal of Experimental Medicine 2003 198 12 1951 1957 2-s2.0-0346962972 10.1084/jem.20030896 (Pubitemid 38032126)
59. Langrish C. L., Chen Y., Blumenschein W. M., Mattson J., Basham B., Sedgwick J. D., McClanahan T., Kastelein R. A., Cua D. J., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. The Journal of Experimental Medicine 2005 201 2 233 240 2-s2.0-13244283212 10.1084/jem.20041257 (Pubitemid 40189432)
60. Vignali D. A. A., Kuchroo V. K., IL-12 family cytokines: immunological playmakers. Nature Immunology 2012 13 8 722 728 10.1038/ni.2366
61. Fletcher J. M., Lalor S. J., Sweeney C. M., Tubridy N., Mills K. H. G., T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clinical and Experimental Immunology 2010 162 1 1 11 2-s2.0-77956536780 10.1111/j.1365-2249.2010.04143.x
62. Carter S. L., Müller M., Manders P. M., Campbell I. L., Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN- γ but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia 2007 55 16 1728 1739 2-s2.0-35349024347 10.1002/glia.20587 (Pubitemid 47612859)
63. Semple B. D., Kossmann T., Morganti-Kossmann M. C., Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. Journal of Cerebral Blood Flow and Metabolism 2010 30 3 459 473 2-s2.0-77649273140 10.1038/jcbfm.2009.240
64. +Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain 2009 132 9 2487 2500 2-s2.0-71549167047 10.1093/brain/awp144
65. 3CR1 in myeloid cell entry in the CNS. Journal of Neuroimmunology 2010 224 1-2 80 84 2-s2.0-77955090344 10.1016/j.jneuroim.2010.05.015
66. + myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 2009 113 14 3190 3197 2-s2.0-65149093082 10.1182/blood-2008-07-168575
67. Huang D., Tani M., Wang J., Han Y., He T. T., Weaver J., Charo I. F., Tuohy V. K., Rollins B. J., Ransohoff R. M., Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice. The Journal of Neuroscience 2002 22 24 10633 10642 2-s2.0-0037115107 (Pubitemid 36005137)
68. Dos Santos A. C., Barsante M. M., Esteves Arantes R. M., Bernard C. C. A., Teixeira M. M., Carvalho-Tavares J., CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis-an intravital microscopy study. Journal of Neuroimmunology 2005 162 1-2 122 129 2-s2.0-17044372405 10.1016/j.jneuroim.2005.01.020
69. Ge S., Shrestha B., Paul D., Keating C., Cone R., Guglielmotti A., Pachter J. S., The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis. Journal of Neuroinflammation 2012 9 1 171 10.1186/1742-2094-9-171
70. Guo X., Nakamura K., Kohyama K., Harada C., Behanna H. A., Watterson D. M., Matsumoto Y., Harada T., Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis. Neuroscience Research 2007 59 4 457 466 2-s2.0-35548931165 10.1016/j.neures.2007.08.014 (Pubitemid 350007814)
71. Chastain E. M. L., Duncan D. S., Rodgers J. M., Miller S. D., The role of antigen presenting cells in multiple sclerosis. Biochimica et Biophysica Acta 2011 1812 2 265 274 2-s2.0-78650171363 10.1016/j.bbadis.2010.07.008
72. Sierra A., Abiega O., Shahraz A., Neumann H., Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Frontiers in Cellular Neuroscience 2013 7 6 10.3389/fncel.2013.00006
73. Napoli I., Neumann H., Protective effects of microglia in multiple sclerosis. Experimental Neurology 2010 225 1 24 28 2-s2.0-77955661661 10.1016/j.expneurol.2009.04.024
74. Takahashi K., Rochford C. D. P., Neumann H., Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. The Journal of Experimental Medicine 2005 201 4 647 657 2-s2.0-14244268775 10.1084/jem.20041611 (Pubitemid 40289554)
75. Takahashi K., Prinz M., Stagi M., Chechneva O., Neumann H., TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Medicine 2007 4 4 675 689 2-s2.0-34247500821 10.1371/journal.pmed.0040124 (Pubitemid 46658770)
76. Kotter M. R., Li W.-W., Zhao C., Franklin R. J. M., Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. The Journal of Neuroscience 2006 26 1 328 332 2-s2.0-30644476095 10.1523/JNEUROSCI.2615-05.2006 (Pubitemid 43089546)
77. Neumann H., Kotter M. R., Franklin R. J. M., Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009 132 2 288 295 2-s2.0-60149098421 10.1093/brain/awn109
78. Olah M., Amor S., Brouwer N., Vinet J., Eggen B., Biber K., Boddeke H. W. G. M., Identification of a microglia phenotype supportive of remyelination. Glia 2012 60 2 306 321 2-s2.0-83055184202 10.1002/glia.21266
79. Vyas J. M., Van Der Veen A. G., Ploegh H. L., The known unknowns of antigen processing and presentation. Nature Reviews Immunology 2008 8 8 607 618 2-s2.0-48749092592 10.1038/nri2368
80. Neefjes J., Jongsma M. L. M., Paul P., Bakke O., Towards a systems understanding of MHC class i and MHC class II antigen presentation. Nature Reviews Immunology 2011 11 12 823 836 2-s2.0-82255164138 10.1038/nri3084
81. Acuto O., Michel F., CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nature Reviews Immunology 2003 3 12 939 951 2-s2.0-0347505003 (Pubitemid 37521536)
82. Villadangos J. A., Schnorrer P., Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nature Reviews Immunology 2007 7 7 543 555 2-s2.0-34250893815 10.1038/nri2103 (Pubitemid 46987783)
83. Mack C. L., Vanderlugt-Castaneda C. L., Neville K. L., Miller S. D., Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis. Journal of Neuroimmunology 2003 144 1-2 68 79 2-s2.0-0142258022 10.1016/j.jneuroim.2003.08.032 (Pubitemid 37329931)
84. Satoh J., Lee Y. B., Kim S. U., T-cell costimulatory molecules B7-1 (CD80) and B7-2 (CD86) are expressed in human microglia but not in astrocytes in culture. Brain Research 1995 704 1 92 96 2-s2.0-0028876151 10.1016/0006- 8993(95)01177-3
85. Tompkins S. M., Padilla J., Dal Canto M. C., Ting J. P.-Y., Van Kaer L., Miller S. D., De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. The Journal of Immunology 2002 168 8 4173 4183 2-s2.0-0037090253 (Pubitemid 34298426)
86. McMahon E. J., Bailey S. L., Castenada C. V., Waldner H., Miller S. D., Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nature Medicine 2005 11 3 335 339 2-s2.0-16244417773 10.1038/nm1202 (Pubitemid 40460563)
87. Starossom S. C., Mascanfroni I. D., Imitola J., Cao L., Raddassi K., Hernandez S. F., Bassil R., Croci D. O., Cerliani J. P., Delacour D., Wang Y., Elyaman W., Khoury S. J., Rabinovich G. A., Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 2012 37 2 249 263
88. Theil M.-M., Miyake S., Mizuno M., Tomi C., Croxford J. L., Hosoda H., Theil J., Von Hörsten S., Yokote H., Chiba A., Lin Y., Oki S., Akamizu T., Kangawa K., Yamamura T., Suppression of experimental autoimmune encephalomyelitis by ghrelin. The Journal of Immunology 2009 183 4 2859 2866 2-s2.0-70149084413 10.4049/jimmunol.0803362
89. Wu M., Nissen J. C., Chen E. I., Tsirka S. E., Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis. PLoS ONE 2012 7 4 2-s2.0-84859841514 10.1371/journal.pone. 0034933 e34933
90. Van Loo G., Sze M., Bougarne N., Praet J., Mc Guire C., Ullrich A., Haegeman G., Prinz M., Beyaert R., De Bosscher K., Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis. Molecular Endocrinology 2010 24 2 310 322 2-s2.0-75149156175 10.1210/me.2009-0236
91. Xu J., Wagoner G., Douglas J. C., Drew P. D., β -Lapachone ameliorization of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 2013 254 1-2 46 54 10.1016/j.jneuroim.2012.09.004
92. Saijo K., Collier J. G., Li A. C., Katzenellenbogen J. A., Glass C. K., An ADIOL-ER β -CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 2011 145 4 584 595 2-s2.0-79955788943 10.1016/j.cell.2011.03.050
93. Wu W. F., Tan X. J., Dai Y. B., Krishnan V., Warner M., Gustafsson J. Å., Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America 2013 110 9 3543 3548 10.1073/pnas.1300313110
94. Beutner C., Lepperhof V., Dann A., Linnartz-Gerlach B., Litwak S., Napoli I., Prinz M., Neumann H., Engineered stem cell-derived microglia as therapeutic vehicle for experimental autoimmune encephalomyelitis. Gene Therapy 2013 2013 10.1038/gt.2012.100